Komo

Benchling

How much has Benchling raised?

Benchling has raised about $412M and was last valued at $6.1B in its 2021 Series F, with later secondary estimates lower.

Total raised
About $412M
Disclosed rounds
Seed through Series F
Latest round
Nov. 2021 $100M Series F
Latest valuation
$6.1B last primary valuation; secondary estimates lower in 2024
First raised
2012 seed
Notable backer
Altimeter, Franklin Templeton, Benchmark, a16z provenance

Benchling's funding rounds

Benchling scaled from lab notebook startup to high-valuation private life-science software platform.

  1. 2012-2019Seed through Series CRaised early venture capital to build ELN and life-science data products.
  2. 2020Series D / E growthExpanded through pandemic-era digitization of biotech R&D.
  3. Nov. 2021Series F — $6.1B valuationRaised $100M co-led by Altimeter and Franklin Templeton.
  4. 2024Secondary resetThird-party secondary estimates suggested lower valuation than 2021 peak, but no new primary round was verified.

Sources:Benchling Series FSacra Benchling funding

How much has Benchling raised in total?

The funding total is approximately $412M across disclosed rounds. Because the latest primary round is from 2021, treat valuation as historical unless a current primary financing is announced.

Who are Benchling's investors?

Investors include Altimeter, Franklin Templeton, Tiger Global, Lone Pine, Benchmark, Thrive, ICONIQ, Lux, and a16z provenance. Their mix reflects both venture and late-stage crossover appetite for vertical SaaS in biotech.

Why did Benchling's valuation move?

The $6.1B valuation reflected 2021 growth-market multiples and category leadership. Secondary estimates later moved lower as software multiples compressed and biotech funding cycles cooled.

Is Benchling profitable, and will it IPO?

Benchling has not disclosed profitability or IPO timing. It is a plausible long-term IPO candidate, but as of June 2026 the company remains private and focused on enterprise R&D adoption and AI.

What does Benchling's funding mean if you sell into them?

Benchling has mature enterprise budgets but sells into regulated scientific workflows, so vendors need strong security, validation, and data-governance stories. Best-fit offers support AI, scientific data, integration, customer success, compliance, and global operations.

As of June 2026.Sources:Benchling Series FSacra Benchling fundinga16z investment lista16z investment list

Benchling — frequently asked questions

Read the full Benchling profile
More on Benchling
How much has Benchling raised — other companies
Agent CTA Background

Revenue work. On autopilot.

Start Free TrialBuilt for revenue teams who care about quality.